2269
COM:WUXIBIOLOGICS
WuXi Biologics
- Stock
Last Close
16.08
14/11 03:05
Market Cap
46.18B
Beta: -
Volume Today
25.81M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 41.74M - | 64.45M 54.43% | 107.27M 66.43% | 181.37M 69.08% | 313.29M 72.74% | 741.79M 136.78% | 1.39B 86.82% | 1.98B 43.18% | 2.02B 1.98% | ||
average payables | 208.60M - | 187.83M 9.96% | 121.16M 35.49% | 179.14M 47.85% | 203.40M 13.54% | 415.91M 104.48% | 631.89M 51.93% | 706.09M 11.74% | 813.83M 15.26% | ||
average receivables | 226.85M - | 375.70M 65.62% | 229.53M 38.91% | 715.35M 211.65% | 715.35M 0% | 5.67B - | |||||
book value per share | 0.11 - | 0.04 60.73% | 0.08 85.25% | 1.25 1,471.09% | 2.20 76.24% | 3.44 56.25% | 5.20 51.26% | 7.73 48.66% | 8.40 8.60% | 9.17 9.13% | |
capex per share | -0.02 - | -0.10 555.05% | -0.13 28.27% | -0.21 69.32% | -0.50 136.16% | -0.87 72.65% | -1.52 75.14% | -1.56 2.55% | -1.41 10.02% | ||
capex to depreciation | -1.21 - | -5.87 386.17% | -4.60 21.53% | -5.60 21.73% | -12.73 127.25% | -14.61 14.77% | -19.88 36.07% | -13.54 31.90% | -7.33 45.87% | ||
capex to operating cash flow | -2.37 - | -3.12 31.47% | -5.24 67.77% | -1.91 63.54% | -2.40 25.91% | -2.68 11.40% | -3.20 19.61% | -1.90 40.64% | -1.06 44.30% | ||
capex to revenue | -0.15 - | -0.60 290.23% | -0.43 27.76% | -0.42 2.03% | -0.72 70.01% | -0.81 12.42% | -1.07 32.21% | -0.63 40.95% | -0.38 39.37% | ||
cash per share | 0.00 - | 0.05 2,560.21% | 0.05 6.87% | 0.64 1,186.29% | 1.12 75.92% | 1.82 61.43% | 2.15 18.17% | 2.67 24.26% | 2.09 21.66% | 2.27 8.93% | |
days of inventory on hand | 58.71 - | 48.42 17.54% | 48.06 0.74% | 51.63 7.43% | 54.67 5.90% | 62.70 14.69% | 128.51 104.95% | 112.78 12.24% | 97.43 13.61% | 63.15 35.19% | |
days payables outstanding | 256.48 - | 262.49 2.34% | 63.90 75.66% | 52.29 18.16% | 53.18 1.70% | 29.17 45.15% | 76.57 162.48% | 41.29 46.08% | 33.93 17.82% | 29.80 12.18% | |
days sales outstanding | 177.48 - | 191.55 7.93% | 169.42 11.56% | 206.04 - | 132.52 - | ||||||
debt to assets | 0.09 - | 0.34 286.07% | 0.57 69.34% | 0.01 - | 0.12 730.95% | 0.12 7.70% | 0.10 15.21% | 0.09 8.55% | 0.08 12.70% | ||
debt to equity | 0.15 - | 3.12 1,995.23% | 4.18 33.74% | 0.02 - | 0.17 873.65% | 0.16 5.59% | 0.13 17.87% | 0.13 5.19% | 0.11 13.40% | ||
dividend yield | 0.00 - | ||||||||||
earnings yield | 0.00 - | 0.00 2.24% | 0.00 194.50% | 0.01 30.87% | 0.01 85.33% | 0.01 22.05% | 0.00 46.40% | 0.01 115.65% | 0.02 84.64% | 0.03 49.72% | |
enterprise value | 25.75B - | 26.95B 4.66% | 29.65B 10.02% | 38.74B 30.68% | 48.78B 25.90% | 105.01B 115.28% | 335.08B 219.09% | 310.55B 7.32% | 220.76B 28.91% | 109.16B 50.55% | |
enterprise value over ebitda | 274.27 - | 215.69 21.36% | 91.20 57.72% | 82.19 9.88% | 47.81 41.83% | 78.88 64.98% | 162.57 106.09% | 71.58 55.97% | 31.72 55.68% | 23.47 26.01% | |
ev to operating cash flow | 1.20K - | 251.50 78.99% | 361.90 43.90% | 107.54 70.28% | 64.05 40.44% | 86.92 35.72% | 178.11 104.91% | 90.51 49.19% | 39.84 55.98% | ||
ev to sales | 77.59 - | 48.38 37.65% | 29.98 38.04% | 23.93 20.16% | 19.25 19.59% | 26.36 36.96% | 59.70 126.49% | 30.18 49.45% | 14.46 52.09% | 6.41 55.68% | |
free cash flow per share | -0.01 - | -0.07 669.19% | -0.10 52.70% | -0.10 0.35% | -0.29 189.63% | -0.55 85.24% | -1.05 92.26% | -0.74 29.33% | -0.08 89.43% | ||
free cash flow yield | -0.00 - | -0.01 641.69% | -0.01 41.86% | -0.01 31.02% | -0.02 142.36% | -0.02 8.07% | -0.01 34.22% | -0.01 19.80% | -0.00 85.04% | ||
graham net net | -0.04 - | -0.24 567.48% | -0.34 43.72% | 0.40 218.45% | 1.07 163.64% | 0.60 43.43% | 0.24 59.80% | 0.15 36.39% | -0.84 643.30% | 0.68 180.64% | |
graham number | 0.17 - | 0.11 35.48% | 0.27 142.33% | 1.48 445.00% | 2.93 97.57% | 4.59 56.66% | 7.07 53.93% | 11.89 68.08% | 14.15 19.04% | 12.62 10.78% | |
income quality | 0.44 - | 1.64 273.39% | 0.47 71.56% | 1.19 154.65% | 1.03 12.98% | 1.07 3.87% | 0.96 10.75% | 0.86 10.21% | 1.03 20.37% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0.05 Infinity% | 0.03 35.89% | 0.02 41.65% | 0.05 142.77% | 0.04 13.32% | 0.04 13.95% | |
interest coverage | 20.66 - | 24.59 18.98% | 8.34 66.06% | 9.77 17.08% | 6.32 35.26% | 56.61 795.15% | 41.14 27.32% | 98.42 139.20% | 95.67 2.79% | ||
interest debt per share | 0.02 - | 0.13 690.79% | 0.34 151.66% | 0.01 96.73% | 0.08 594.79% | 0.60 673.81% | 0.85 43.36% | 1.04 21.65% | 1.08 3.52% | 1.00 6.85% | |
inventory turnover | 6.22 - | 7.54 21.27% | 7.60 0.75% | 7.07 6.92% | 6.68 5.57% | 5.82 12.81% | 2.84 51.21% | 3.24 13.95% | 3.75 15.75% | 5.78 54.30% | |
invested capital | 0.15 - | 3.12 1,995.23% | 4.18 33.74% | 0.02 - | 0.17 873.65% | 0.16 5.59% | 0.13 17.87% | 0.13 5.19% | 0.11 13.40% | ||
market cap | 25.70B - | 26.65B 3.71% | 28.69B 7.64% | 39.25B 36.82% | 52.86B 34.69% | 109.02B 106.24% | 338.85B 210.81% | 315.26B 6.96% | 222.74B 29.35% | 114.42B 48.63% | |
net current asset value | -35.68M - | -609.60M 1,608.38% | -884.67M 45.12% | 2.21B 349.68% | 4.35B 96.77% | 4.97B 14.25% | 6.14B 23.65% | 8.20B 33.60% | 5.12B 37.60% | 8.64B 68.81% | |
net debt to ebitda | 0.53 - | 2.38 352.13% | 2.95 24.02% | -1.07 136.18% | -4.00 274.54% | -3.01 24.73% | -1.83 39.40% | -1.09 40.58% | -0.28 73.87% | -1.13 299.06% | |
net income per share | 0.01 - | 0.01 6.03% | 0.04 217.01% | 0.08 89.05% | 0.17 121.48% | 0.27 57.07% | 0.43 56.65% | 0.81 90.02% | 1.06 30.48% | 0.77 27.06% | |
operating cash flow per share | 0.01 - | 0.03 398.26% | 0.02 23.55% | 0.11 364.37% | 0.21 87.56% | 0.33 54.97% | 0.48 46.43% | 0.82 72.74% | 1.33 61.54% | ||
payables turnover | 1.42 - | 1.39 2.29% | 5.71 310.77% | 6.98 22.20% | 6.86 1.67% | 12.51 82.30% | 4.77 61.90% | 8.84 85.44% | 10.76 21.68% | 12.25 13.87% | |
receivables turnover | 2.06 - | 1.91 7.35% | 2.15 13.07% | 1.77 - | 2.75 - | ||||||
research and ddevelopement to revenue | 0.11 - | 0.07 32.40% | 0.05 24.49% | 0.05 14.60% | 0.07 45.18% | 0.07 2.42% | 0.05 16.97% | 0.05 9.93% | 0.04 8.26% | 0.05 3.16% | |
return on tangible assets | 0.07 - | 0.03 50.24% | 0.07 116.67% | 0.05 26.70% | 0.07 36.11% | 0.06 15.91% | 0.06 0.23% | 0.08 35.92% | 0.09 15.11% | 0.06 33.03% | |
revenue per share | 0.10 - | 0.16 67.86% | 0.29 77.55% | 0.50 72.83% | 0.70 38.91% | 1.07 53.57% | 1.42 32.48% | 2.47 73.65% | 3.66 48.42% | 3.87 5.80% | |
roe | 0.11 - | 0.30 170.03% | 0.52 71.12% | 0.06 87.97% | 0.08 25.66% | 0.08 0.53% | 0.08 3.56% | 0.10 27.82% | 0.13 20.14% | 0.08 33.16% | |
roic | 0.11 - | 0.07 33.55% | 0.11 59.50% | 0.07 35.78% | 0.09 27.76% | 0.07 29.22% | 0.06 5.67% | 0.09 44.65% | 0.13 43.07% | 0.08 40.90% | |
sales general and administrative to revenue | 0.13 - | 0.13 1.39% | 0.09 25.00% | 0.08 12.63% | 0.09 8.53% | 0.09 2.61% | 0.09 1.16% | 0.09 6.59% | 0.08 2.32% | 0.09 5.57% | |
shareholders equity per share | 0.11 - | 0.04 60.73% | 0.08 85.25% | 1.25 1,471.09% | 2.20 76.24% | 3.44 56.25% | 5.20 51.26% | 7.73 48.66% | 8.40 8.60% | 9.17 9.13% | |
stock based compensation to revenue | 0.01 - | 0.05 235.75% | 0.05 0.30% | 0.04 16.39% | 0.05 26.00% | 0.05 1.07% | 0.05 3.81% | 0.05 4.98% | 0.08 56.39% | 0.08 3.37% | |
tangible asset value | 371.83M - | 146.00M 60.73% | 270.47M 85.25% | 4.02B 1,387.93% | 7.49B 86.21% | 12.29B 64.07% | 20.32B 65.29% | 30.58B 50.45% | 34.13B 11.64% | 41.98B 22.97% | |
tangible book value per share | 0.11 - | 0.04 60.73% | 0.08 85.25% | 1.25 1,471.09% | 2.06 65.22% | 3.31 60.29% | 5.14 55.43% | 7.33 42.50% | 8.18 11.66% | 9.54 16.62% | |
working capital | -31.74M - | -600.82M 1,793.11% | 29.03M 104.83% | 2.24B 7,599.89% | 4.43B 98.02% | 6.80B 53.64% | 9.71B 42.72% | 11.27B 16.15% | 9.15B 18.83% | 13.56B 48.20% |
All numbers in (except ratios and percentages)